Annual report pursuant to Section 13 and 15(d)

QUARTERLY FINANCIAL DATA (Unaudited)

v3.20.2
QUARTERLY FINANCIAL DATA (Unaudited)
12 Months Ended
Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract]  
QUARTERLY FINANCIAL DATA (Unaudited)

QUARTERLY FINANCIAL DATA
(Unaudited
 )

 

As described in the “Explanatory Note” prior to Part I to this comprehensive Annual Report, the following unaudited quarterly periods for the three-months ending March 31, the three and six month periods ending June 30 and the three and nine month periods ending September 30 for each year 2019, 2018, 2017 and 2016, and the respective periods for comparative purposes are being filed herein and in lieu of the filing Quarterly Reports on Form 10-Q for 2019, 2018, 2017 and 2016. The quarterly information for 2015 was previously filed in three Forms 10-Q that were filed in 2015. The quarterly information in 2015 reflects the Mexico Jatropha operations that were discontinued in the fourth quarter of 2015.

 

The following unaudited interim financial statements have been prepared pursuant to the rules and regulations of the SEC. The footnote disclosures normally included in financial statements prepared in accordance with United States generally accepted accounting principles (GAAP) have been omitted.. These unaudited statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information contained therein. Interim results are not necessarily indicative of results for a full year.

 

The following unaudited financial statements should be read in conjunction with the audited financial statements and notes thereto included above in this Annual Report for the year ended December 31, 2019. The accounting policies in preparation of interim reports are the same as those used for the above audited annual reports included in this Annual Report.

 

CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

    As of March 31,
    2019   2018   2017
ASSETS            
CURRENT ASSETS                        
Cash and cash equivalents   $ 4,166,517     $ 285,890     $ 63,244  
Accounts receivable     —         19,082       —    
Inventory     22,942       22,942       22,942  
Total Current Assets     4,189,459       327,914       86,186  
                         
PROPERTY AND EQUIPMENT, NET     1,706       1,706       1,706  
RIGHT-OF-USE ASSET     104,000       —         —    
INTANGIBLE ASSETS, NET     2,685,512       2,930,738       3,175,965  
DEBT ISSUANCE COSTS     —         —         —    
PRE-ACQUISITION COSTS     —         —         —    
DEPOSITS     5,253       5,253       5,253  
                         
TOTAL ASSETS   $ 6,985,930     $ 3,265,611     $ 3,269,110  
                         
                         
LIABILITIES AND STOCKHOLDERS’ DEFICIT                        
CURRENT LIABILITIES                        
Accounts payable and accrued expenses   $ 3,916,364     $ 2,854,488     $ 2,837,354  
Accrued compensation and related liabilities     1,469,100       2,006,031       1,625,199  
Accrued interest     1,462,941       1,130,519       815,802  
Lease liabilities     104,000       —         —    
Notes payable     1,369,856       1,369,856       1,369,856  
Convertible notes payable     697,000       697,000       697,000  
Derivative liability     15,854,000       —         —    
Total Current Liabilities     24,873,261       8,057,894       7,345,211  
                         
LONG-TERM LIABILITIES                        
Convertible notes payable     1,000,000       —         —    
                         
TOTAL LIABILITIES     25,873,261       8,057,894       7,345,211  
                         
STOCKHOLDERS’ DEFICIT                        
Series A preferred stock     13       13       13  
Common stock     341,529       341,529       341,529  
Additional paid-in capital     30,712,228       30,610,179       30,599,931  
Accumulated deficit     (49,941,101 )     (35,744,004 )     (35,017,574 )
Total Stockholders' Deficit     (18,887,331 )     (4,792,283 )     (4,076,101 )
                         
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT   $ 6,985,930     $ 3,265,611     $ 3,269,110  

 

CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

    As of March 31,
    2016
ASSETS        
CURRENT ASSETS        
Cash and cash equivalents   $ 2,256  
Accounts receivable     13,595  
Inventory     25,921  
Other current assets     100,149  
Total Current Assets     141,921  
         
PROPERTY AND EQUIPMENT, NET     7,094  
RIGHT-OF-USE ASSET     —    
INTANGIBLE ASSETS, NET     3,421,191  
OTHER NONCURRENT ASSETS     2,626  
         
TOTAL ASSETS   $ 3,572,832  
         
         
LIABILITIES AND STOCKHOLDERS' DEFICIT        
CURRENT LIABILITIES        
Accounts payable and accrued expenses   $ 3,060,695  
Accrued compensation and related liabilities     1,435,216  
Accrued interest     528,573  
Notes payable     1,369,856  
Convertible notes payable     697,000  
Derivative liability     106,000  
Total Current Liabilities     7,197,340  
         
LONG-TERM LIABILITIES        
Accrued interest payable     —    
Accrued return on noncontrolling interest     —    
Mortgage notes payable     —    
Total Long-Term Liabilities     —    
         
STOCKHOLDERS' DEFICIT        
Series A preferred stock     13  
Common stock     341,405  
Additional paid-in capital     30,559,890  
Accumulated deficit     (34,629,719 )
Accumulated other comprehensive income     103,903  
Total Stockholders' Deficit     (3,624,508 )
         
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT   $ 3,572,832  

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the three months ended March 31,
    2019   2018   2017
             
REVENUE   $ —       $ —       $ 50,334  
                         
OPERATING EXPENSES                        
General and administrative     1,027,577       126,664       216,869  
Amortization of intangible assets     61,307       61,307       61,307  
Preliminary stage acquisition costs     934,243       —         —    
Total Operating Expenses     2,023,127       187,971       278,176  
                         
OPERATING LOSS     (2,023,127 )     (187,971 )     (227,842 )
                         
OTHER INCOME (EXPENSE)                        
Other Income (Expense)     —         425,000       —    
Interest expense, net     (90,529 )     (80,631 )     (77,302 )
Gain on settlement of liabilities     —         —         —    
Change in fair value derivative and finance                        
charges related to derivative liability     (3,937,000 )     344,369       —    
Other Income (Expense), Net     (4,027,529 )     —         (77,302 )
                         
NET (LOSS)/INCOME   $ (6,050,656 )   $ 156,398     $ (305,144 )
                         
BASIC AND DILUTED LOSS PER COMMON SHARE:                        
Net Loss per Common Share   $ (0.02 )   $ 0.00     $ (0.00 )
                         
BASIC AND DILUTED WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING     341,529,434       341,529,434       341,529,434  

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the three months ended March 31,
    2016
     
REVENUE   $ 121,647  
         
OPERATING EXPENSES        
General and administrative     454,060  
Other operating     —    
Total Operating Expenses     454,060  
         
OPERATING LOSS     (332,413 )
         
OTHER INCOME (EXPENSE)        
Other Income (Expense)     (12,820 )
Interest expense, net     (73,517 )
Gain on settlement of liabilities     —    
Change in fair value derivative     —    
Foreign currency transaction gain (loss)     —    
Total Other Income (Expense)     (86,337 )
         
NET LOSS   $ (418,750 )

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the three months ended March 31,
    2019   2018   2017
Operating Activities:                        
Net loss   $ (6,050,656 )   $ 156,398     $ (305,144 )
Adjustments to reconcile net loss to net cash used in operating activities:                        
Gain on settlement of liabilities     —         —         —    
Share-based compensation     43,008       10,248       35,560  
Depreciation and amortization     61,306       61,307       61,307  
Change in fair value of derivative liability     3,397,000       —         —    
Changes in operating assets and liabilities:                        
Accounts receivable     —         —         112,254  
Inventory     —         —         —    
Accounts payable and accrued expenses     858,863       (26,427 )     32,130  
Accrued compensation and related liabilities     (21 )     —         26,944  
Interest payable     90,528       80,631       78,029  
Other Operating Activities     —         —         —    
Net Cash Used in Operating Activities     (1,059,972 )     282,157       41,080  
Investing Activities:                        
Pre-acquisition costs     —         —         —    
Cash received from derivative forward contract     —         —         —    
Net Cash Used in Investing Activities     —         —         —    
Financing Activities:                        
Debt issuance costs     —         —         —    
Proceeds from exercise of stock options     —         —         —    
Net Cash Used in Financing Activities     —         —         —    
                         
Net Change in Cash and Cash Equivalents     (1,059,972 )     282,157       41,080  
Cash and Cash Equivalents at Beginning of Period     5,226,489       3,733       22,164  
Cash and Cash Equivalents at End of Period   $ 4,166,517     $ 285,890     $ 63,244  

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the three months ended March 31,
    2016
Operating Activities:        
Net loss   $ (418,750 )
Adjustments to reconcile net loss to net cash used in operating activities:        
Foreign currency transaction gain     —    
Gain on settlement of liabilities     —    
Share-based compensation     26,705  
Write-down of long-lived assets        
Depreciation and amortization     62,096  
Amortization of debt discount     —    
Change in fair value of derivative liability     —    
Changes in operating assets and liabilities:        
Accounts receivable     —    
Inventory     623  
Accounts payable and accrued expenses     150,185  
Accrued compensation and related liabilities     —    
Interest payable     —    
Other Operating Activities     —    
Other noncurrent assets     —    
Other current assets     (4,460 )
Net Cash Used in Operating Activities:     (183,601 )
Cash Flows of discontinued operations:        
Operating cash flows     153,758  
Investing cash flows     —    
Financing cash flows (including cash at year-end)     —    
Net Cash flows from discontinued operations     153,758  
         
Effect of exchange rate changes on cash     (2,605 )
         
Net Change in Cash and Cash Equivalents     (32,448 )
Cash and Cash Equivalents at Beginning of Period     34,704  
Cash and Cash Equivalents at End of Period   $ 2,256  

 

CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

    As of June 30,
    2019   2018   2017
ASSETS            
CURRENT ASSETS                        
Cash and cash equivalents   $ 2,275,500     $ 161,014     $ 64,978  
Accounts receivable     —         19,082       25,081  
Inventory     22,942       22,942       22,942  
Total Current Assets     2,298,442       203,038       113,001  
                         
PROPERTY AND EQUIPMENT, NET     1,706       1,706       1,706  
RIGHT-OF-USE ASSET     98,000       —         —    
INTANGIBLE ASSETS, NET     2,624,205       2,869,432       3,114,659  
DEBT ISSUANCE COSTS     100,000       —         —    
PRE-ACQUISITION COSTS     755,382       —         —    
DEPOSITS     505,253       5,253       5,253  
                         
TOTAL ASSETS   $ 6,382,988     $ 3,079,429     $ 3,234,619  
                         
                         
LIABILITIES AND STOCKHOLDERS' DEFICIT                        
CURRENT LIABILITIES                        
Accounts payable and accrued expenses   $ 3,939,808     $ 2,808,299     $ 2,879,783  
Accrued compensation and related liabilities     1,469,100       2,003,482       1,652,143  
Accrued interest     1,553,470       1,211,150       967,545  
Lease liabilities     98,000       —         —    
Notes payable     1,369,856       1,369,856       1,369,856  
Convertible notes payable     697,000       697,000       697,000  
Derivative liability     14,536,000       —         —    
Total Current Liabilities     23,663,234       8,089,787       7,566,327  
                         
LONG-TERM LIABILITIES                        
Convertible notes payable     1,000,000       —         —    
                         
TOTAL LIABILITIES     24,663,234       8,089,787       7,566,327  
                         
STOCKHOLDERS' DEFICIT                        
Series A preferred stock     13       13       13  
Common stock     341,529       341,529       341,529  
Additional paid-in capital     31,179,041       30,669,220       30,599,931  
Accumulated deficit     (49,800,829 )     (36,021,120 )     (35,273,181 )
Total Stockholders' Deficit     (18,280,246 )     (5,010,358 )     (4,331,708 )
                         
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT   $ 6,382,988     $ 3,079,429     $ 3,234,619  

 

CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

    As of June 30,
    2016
ASSETS        
CURRENT ASSETS        
Cash and cash equivalents   $ 12,205  
Accounts receivable     62,924  
Inventory     24,431  
Other current assets     —    
Total Current Assets     99,560  
         
PROPERTY AND EQUIPMENT, NET     5,453  
RIGHT-OF-USE ASSET     —    
INTANGIBLE ASSETS, NET     3,359,885  
OTHER NONCURRENT ASSETS     2,626  
         
TOTAL ASSETS   $ 3,467,524  
         
         
LIABILITIES AND STOCKHOLDERS’ DEFICIT        
CURRENT LIABILITIES        
Accounts payable and accrued expenses   $ 3,011,834  
Accrued compensation and related liabilities     1,228,969  
Accrued interest     633,173  
Notes Payable     1,369,856  
Convertible notes payable     697,000  
Derivative liability     —    
Total Current Liabilities     6,940,832  
         
LONG-TERM LIABILITIES        
Accrued interest payable     —    
Accrued return on non-controlling interest     —    
Mortgage notes payable     —    
Total Long-Term Liabilities     —    
         
TOTAL LIABILITIES        
      6,940,832  
STOCKHOLDERS’ DEFICIT        
Series A preferred stock     13  
Common stock     341,529  
Additional paid-in capital     30,564,371  
Accumulated deficit     (34,379,221 )
Accumulated other comprehensive income     —    
Total Stockholders' Deficit     (3,473,308 )
Noncontrolling interests     —    
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT   $ 3,467,524  

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the three months ended June 30,
    2019   2018   2017
             
Revenue   $ —       $ —       $ 109,539  
                         
Operating Expenses                        
General and Administrative     937,765       135,178       179,566  
Amortization of intangible assets     61,306       61,306       61,306  
Preliminary stage acquisition costs     82,693       —         —    
Total Operating Expenses     1,081,764       196,484       240,872  
                         
Operating Loss     (1,081,764 )     (196,484 )     (131,333 )
                         
Other Income (Expense)                        
Other Income (Expenses)     —         —         28,279  
Interest expense, net     (89,546 )     (80,632 )     (152,553 )
Gain on settlement of liabilities     —         —         —    
Change in fair value derivative and finance     —         —         —    
charges related to derivative liability     1,318,000       —         —    
Other Income (Expense), Net     1,228,454       (80,632 )     (124,274 )
                         
Net (Loss)/Income   $ 149,690     $ (277,116 )   $ (255,607 )
                         
Basic and diluted Loss per Common Share:                        
Net Loss per Common Share   $ (0.00 )   $ 0.00     $ (0.00 )
                         
Basic and diluted Weighted-Average Common Shares Outstanding     341,546,009       341,529,434       341,529,434  

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the three months ended June 30,
    2016
     
Revenue   $ 79,583  
         
Operating Expenses     —    
General and Administrative     401,838  
Other Operating     —    
Total Operating Expenses     401,838  
         
Operating Loss     (322,255 )
         
Other Income (Expense)        
Other Income (Expense)     67,349  
Interest expense, net     (138,770 )
Gain on settlement of liabilities     537,612  
Change in fair value derivative     —    
Foreign currency transaction gain (loss)     106,563  
Total Other Income (Expense), Net     572,753  
         
Loss from Continuing Operations     250,498  
         
Loss from Discontinued Operations     —    
         
Net (Loss)/Income   $ 250,498  
         
         
Basic and diluted Loss per Common Share:        
Net Loss per Common Share   $ (0.00 )
         
Basic and diluted Weighted-Average Common Shares Outstanding     341,529,434  

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the six months ended June 30,
    2019   2018   2017
             
Revenue   $ —       $ —       $ 159,873  
                         
Operating Expenses                        
General and Administrative     1,065,342       261,842       396,434  
Amortization of intangible assets     122,613       122,613       122,613  
Preliminary stage acquisition costs     1,016,936       —         —    
Total Operating Expenses     3,104,891       384,455       519,047  
                         
Operating Loss     (3,104,891 )     (384,455 )     (359,174 )
                         
Other Income (Expense)                        
Other Income (Expense)     —         425,000       28,279  
Interest expense, net     (180,075 )     (161,263 )     (229,856 )
Gain on settlement of liabilities     —         —         —    
Change in fair value derivative and finance charges related to derivative liability     (2,619,000 )     —         —    
Other Income (Expense), Net     (2,799,075 )     263,737       (201,577 )
                         
Net Loss   $ (5,903,966 )   $ (120,718 )   $ (560,751 )
                         
Basic and diluted Loss per Common Share:                        
Net Loss per Common Share   $ (0.02 )   $ (0.00 )   $ (0.00 )
                         
Basic and diluted Weighted-Average Common Shares Outstanding     341,546,009       341,529,434       341,529,434  

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the six months ended June 30,
    2016
     
Revenue   $ 201,230  
         
Operating Expenses        
General and Administrative     855,898  
Other operating     —    
Total Operating Expenses     855,899  
         
Operating Loss     (654,668 )
         
Other Income (Expense)        
Other Income (Expense)     54,528  
Interest expense, net     (212,287 )
Gain on settlement of liabilities     537,612  
Change in fair value derivative     —    
Foreign currency transaction gain (loss)     105,563  
Total Other Income (Expense), Net     486,416  
         
Net Loss   $ (168,252 )
         
Basic and diluted Loss per Common Share:        
Net Loss per Common Share   $ (0.00 )
         
Basic and diluted Weighted-Average Common Shares Outstanding     341,149,556  
         
Statement of Comprehensive Income        
Net Loss   $ (168,252 )
Other comprehensive loss-foreign currency translation adjustment     —    
Comprehensive Loss   $ (168,252 )

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the three months ended June 30,
    2019   2018   2017
Operating Activities:                        
Net loss   $ 146,690     $ (277,116 )   $ (255,607 )
Adjustments to reconcile net loss to net cash                        
 used in operating activities:                        
Gain on settlement of liabilities     —         —         —    
Share-based compensation     460,395       59,041       —    
Depreciation and amortization     61,307       61,306       61,306  
Change in fair value of derivative liability     (1,318,000 )     —         —    
Changes in operating assets and liabilities:                        
Accounts receivable     —         —         (25,081 )
Inventory     —         —         —    
Accounts payable and accrued expenses     23,444       (46,189 )     42,429  
Accrued compensation and related liabilities     —         (2,549 )     26,944  
Interest payable     90,529       80,631       151,743  
Other Operating Activities     —         —         —    
Net Cash Used in Operating Activities     (535,635 )     (124,876 )     1,734  
Investing Activities:                        
Pre-acquisition costs and deposits     (1,255,382 )     —         —    
Cash received from derivative forward contract     —         —         —    
Net Cash Used in Investing Activities     (1,255,382 )     —         —    
Financing Activities:                        
Debt issuance costs     (100,000 )     —         —    
Proceeds from exercise of stock options     —         —         —    
Net Cash Used in Financing Activities     (100,000 )     —         —    
                         
Net change in Cash and Cash Equivalents     (1,891,017 )     (124,876 )     1,734  
Cash and Cash Equivalents at Beginning of Period     4,166,517       285,890       63,244  
Cash and Cash Equivalents at End of Period   $ 2,275,500     $ 161,014     $ 64,978  

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the three months ended June 30,
    2016
Operating Activities:        
Net loss   $ 250,498  
Adjustments to reconcile net loss to net cash        
 used in operating activities:        
Foreign currency transaction gain     —    
Gain on settlement of liabilities     (255,752 )
Share-based compensation     4,606  
Write-down of long lived assets     —    
Depreciation and amortization     62,933  
Amortization of debt discount     —    
Change in fair value of derivative     (106,000 )
Changes in operating assets and liabilities:        
Accounts receivable     (52,764 )
Inventory     1,490  
Accounts payable and accrued expenses     (179,963 )
Accrued compensation and related liabilities     104,566  
Interest payable     178,144  
Other Operating Activities     —    
Other noncurrent assets     —    
Other current assets     41,306  
Net Cash Used in Operating Activities     49,063  
Investing Activities:        
Plantation developments costs        
Net Cash Used in Investing Activities     —    
Financing Activities:        
Proceeds from issuance of preferred membership in GCE Mexico I, LLC     —    
Net Cash Provided by Financing Activities     —    
Cash Flows of discontinued operations:        
Operating cash flows     64,257  
Investing cash flows     —    
Financing cash flows (including cash at year-end)     —    
Net Cash flows from discontinued operations     64,257  
         
Effect of exchange rate changes on cash     (103,371 )
         
Net change in Cash and Cash Equivalents     9,949  
Cash and Cash Equivalents at Beginning of Period     2,256  
Cash and Cash Equivalents at End of Period   $ 12,205  

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the six months ended June 30,
    2019   2018   2017
Operating Activities:                        
Net loss   $ (5,903,966 )   $ (120,718 )   $ (560,751 )
Adjustments to reconcile net loss to net cash used in operating activities:                        
Gain on settlement of liabilities     —         —         —    
Share-based compensation     503,403       69,289       35,560  
Depreciation and amortization     122,613       122,613       122,613  
Change in fair value of derivative liability     2,619,000       —         —    
Changes in operating assets and liabilities:                        
Accounts receivable     —         —         87,173  
Inventory     —         —         —    
Accounts payable and accrued expenses     882,307       (72,616 )     74,559  
Accrued compensation and related liabilities     (21 )     (2,549 )     53,889  
Interest payable     181,057       161,262       229,771  
Other Operating Activities     —         —         —    
Net Cash Used in Operating Activities     (1,595,607 )     157,281       42,814  
Investing Activities:                        
Pre-acquisition costs and deposits     (1,255,382 )     —         —    
Net Cash Used in Investing Activities     (1,255,382 )     —         —    
Financing Activities:                        
Debt issuance costs     (100,000 )     —         —    
Proceeds from exercise of stock options     —         —         —    
Net Cash Used in Financing Activities     (100,000 )     —         —    
                         
Net change in Cash and Cash Equivalents     (2,950,989 )     157,281       42,814  
Cash and Cash Equivalents at Beginning of Period     5,226,489       3,733       22,164  
Cash and Cash Equivalents at End of Period   $ 2,275,500     $ 161,014     $ 64,978  

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the six months ended June 30,
    2016
Operating Activities:        
Net loss   $ (168,252 )
Adjustments to reconcile net loss to net cash used in operating activities:        
Foreign currency transaction gain     —    
Gain on settlement of liabilities     (255,752 )
Share-based compensation     31,311  
Depreciation and amortization     125,029  
Amortization of debt discount     —    
Change in fair value of derivative     (106,000 )
Changes in operating assets and liabilities:        
Accounts receivable     (52,764 )
Inventory     2,113  
Accounts payable and accrued expenses     (29,778 )
Accrued compensation and related liabilities     104,566  
Interest payable     178,144  
Other current assets     36,846  
Other noncurrent assets     —    
Net Cash Used in Operating Activities     (134,538 )
Investing Activities:        
Plantation developments costs     —    
Net Cash Used in Investing Activities     —    
Financing Activities:        
Proceeds from issuance of preferred membership in GCE Mexico I, LLC     —    
Net Cash Provided by Financing Activities     —    
Cash Flows of discontinued operations:        
Operating cash flows     218,015  
Investing cash flows     —    
Financing cash flows (including cash at year-end)     —    
Net Cash flows from discontinued operations     218,015  
         
Effect of exchange rate changes on cash     (105,976
         
Net change in Cash and Cash Equivalents     (22,499 )
Cash and Cash Equivalents at Beginning of Period     34,704  
Cash and Cash Equivalents at End of Period   $ 12,205  

 

CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

    As of September 30,
    2019   2018   2017
ASSETS            
CURRENT ASSETS                        
Cash and cash equivalents   $ 217,214     $ 57,414     $ 70,996  
Accounts receivable     —         19,082       —    
Inventory     22,942       22,942       22,942  
Total Current Assets     240,156       99,438       93,938  
                         
PROPERTY AND EQUIPMENT, NET     1,706       1,706       1,706  
RIGHT-OF-USE ASSET     89,911       —         —    
INTANGIBLE ASSETS, NET     2,562,899       2,808,125       3,053,352  
DEBT ISSUANCE COSTS     250,000       —         —    
PRE-ACQUISITION COSTS     1,861,481       —         —    
DEPOSITS     1,005,253       5,253       5,253  
                         
TOTAL ASSETS   $ 6,011,406     $ 2,914,522     $ 3,154,249  
                         
                         
LIABILITIES AND STOCKHOLDERS' DEFICIT                        
CURRENT LIABILITIES                        
Accounts payable and accrued expenses   $ 3,779,971     $ 2,832,289     $ 2,944,450  
Accrued compensation and related liabilities     1,469,100       2,003,482       1,679,087  
Accrued interest     1,643,998       1,291,782       1,008,717  
Lease liabilities     90,083       —         —    
Notes payable     1,369,856       1,369,856       1,369,856  
Convertible notes payable     1,697,000       697,000       697,000  
Derivative liability     14,130,000       —         —    
Total Current Liabilities     24,180,008       8,194,409       7,699,110  
                         
LONG-TERM LIABILITIES                        
Convertible notes payable     —         —         —    
                         
TOTAL LIABILITIES     24,180,008       8,194,409       7,699,110  
                         
STOCKHOLDERS' DEFICIT                        
Series A preferred stock     13       13       13  
Common stock     344,029       341,529       341,529  
Additional paid-in capital     31,216,468       30,669,220       30,599,931  
Accumulated deficit     (49,729,112 )     (36,290,649 )     (35,486,334 )
Total Stockholders' Deficit     (18,168,602 )     (5,279,887 )     (4544,861 )
                         
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT   $ 6,011,406     $ 2,914,522     $ 3,154,249  

 

CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

    As of September 30,
    2016
ASSETS        
CURRENT ASSETS        
Cash and cash equivalents   $ 17,179  
Accounts receivable     87,589  
Inventory     23,686  
Other current assets     —    
Total Current Assets     128,454  
         
PROPERTY AND EQUIPMENT, NET     3,812  
RIGHT-OF-USE ASSET     —    
INTANGIBLE ASSETS, NET     3,298,578  
OTHER NONCURRENT ASSETS     5,253  
         
TOTAL ASSETS   $ 3,436,097  
         
         
LIABILITIES AND STOCKHOLDERS' DEFICIT        
CURRENT LIABILITIES        
Accounts payable and accrued expenses   $ 2,917,748  
Accrued compensation and related liabilities     1,283,056  
Accrued interest     685,474  
Notes Payable     1,369,856  
Convertible notes payable     697,000  
Derivative liability     —    
Total Current Liabilities     6,953,134  
         
LONG-TERM LIABILITIES        
Accrued interest payable     —    
Accrued return on non-controlling interest     —    
Mortgage notes payable     —    
Total Long-Term Liabilities     6,953,134  
         
TOTAL LONG-TERM LIABILITIES     6,953,134  
         
STOCKHOLDERS' DEFICIT        
Series A preferred stock     13  
Common stock     341,529  
Additional paid-in capital     30,564,371  
Accumulated deficit     (34,422,950 )
Accumulated other comprehensive income     —    
Total Stockholders' Deficit     (3,517,037 )
Noncontrolling interests     —    
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT   $ 3,436,097  

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the three months ended September 30,
    2019   2018   2017
             
Revenue   $ —       $ —       $ 179,288  
                         
Operating Expenses                        
General and Administrative     126,509       127,591       289,158  
Amortization of intangible assets     61,307       61,307       61,307  
Preliminary stage acquisition costs     106,381       —         —    
Total Operating Expenses     294,197       188,898       350,465  
                         
Operating Loss     (294,197 )     (188,898 )     (171,177 )
                         
Other Income (Expense)                        
Other Income (Expense)     —         —         —    
Interest expense, net     (89,401 )     (80,631 )     (41,976 )
Gain on settlement of liabilities     —         —         —    
Change in fair value derivative and finance     —         —         —    
charges related to derivative liability     406,000       —         —    
Other Income (Expense), Net     316,599       (80,631 )     (41,976 )
                         
Net (Loss)/Income   $ 22,402       (269,529 )     (213,153 )
                         
Basic and diluted Loss per Common Share:                        
Net Loss per Common Share     (0.00 )     (0.00 )     (0.00 )
                 
Basic and diluted Weighted-Average Common Shares Outstanding     341,529,434       341,529,434       341,529,434  

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the three months ended September 30,
    2016
     
Revenue   $ 117,087  
         
Operating Expenses        
General and Administrative     150,299  
Other Operating     —    
Total Operating Expenses     150,299  
         
Operating Loss     (33,212 )
         
Other Income (Expense)        
Other Income (Expense)     3,635  
Interest expense, net     (14,152 )
Gain on settlement of liabilities     —    
Change in fair value derivative     —    
Foreign currency transaction gain (loss)     —    
Total Other Income (Expense), Net     (10,517 )
         
Loss from Continuing Operations     (43,729 )
         
Loss from Discontinued Operations     —    
         
Net Loss   $ (43,729 )
         
Basic and diluted Loss per Common Share:        
Net Loss per Common Share   $ (0.00 )
         
Basic and diluted Weighted-Average Common Shares Outstanding     341,529,454  
         
Statement of Comprehensive Income        
Net Loss   $ (43,729 )
Other comprehensive income (loss)-foreign currency translation adjustment     —    
Comprehensive Loss   $ (43,729 )

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the nine months ended September 30,
    2019   2018   2017
             
Revenue   $ —       $ —       $ 339,161  
                         
Operating Expenses                        
General and Administrative     2,048,954       389,433       685,592  
Amortization of intangible assets     183,920       183,920       183,920  
Preliminary stage acquisition costs     1,123,317       —         —    
Total Operating Expenses     3,356,191       573,353       869,512  
                         
Operating Loss     (3,356,191 )     (573,353 )     (530,351 )
                         
Other Income (Expense)                        
Other Income (Expense)     —         425,000       28,279  
Interest expense, net     (269,476 )     (241,894 )     (271,832 )
Gain on settlement of liabilities     —         —         —    
Change in fair value derivative and finance     —         —         —    
charges related to derivative liability     (2,213,000 )     —         —    
Other Income (Expense), Net     (2,482,476 )     (183,106 )     (243,553 )
                         
Net Loss   $ (5,838,667 )   $ (390,247 )   $ (773,904 )
                         
Basic and diluted Loss per Common Share:                        
Net Loss per Common Share   $ (0.02 )   $ (0.00 )   $ (0.00 )
                         
Basic and diluted Weighted-Average Common Shares Outstanding     342,208,921       341,529,434       341,529,434  

 

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

    For the nine months ended September 30,
    2016
     
Revenue   $ 318,317  
         
Operating Expenses        
General and Administrative     1,006,197  
Other Operating     —    
Total Operating Expenses     1,006,197  
         
Operating Loss     (687,880 )
         
Other Income (Expense)        
Other Income (Expense)     58,163  
Interest expense, net     (226,439 )
Gain on settlement of liabilities     537,612  
Change in fair value derivative     —    
Foreign currency transaction gain (loss)     106,563  
Total Other Income (Expense), Net     475,899  
         
Net Loss   $ (211,981 )
         
         
Basic and diluted Loss per Common Share:        
Net Loss per Common Share   $ (0.00 )
         
Basic and diluted Weighted-Average Common Shares Outstanding     341,529,454  
         
         
Statement of Comprehensive Income        
Net Loss   $ (211,981 )
Other comprehensive income (loss)-foreign currency translation adjustment     —    
Comprehensive Loss   $ (211,981 )

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the three months ended September 30,
    2019   2018   2017
Operating Activities:                        
Net loss   $ 22,402     $ (269,529 )   $ (213,153 )
                         
Adjustments to reconcile net loss to net cash used in operating activities:                        
Gain on settlement of liabilities     —         —         —    
Share-based compensation     71,742       —         —    
Depreciation and amortization     61,306       61,307       61,307  
Change in fair value of derivative liability     (406,000 )     —         —    
Changes in operating assets and liabilities:                        
Accounts receivable     —         —         25,081  
Inventory     —         —         —    
Accounts payable and accrued expenses     (159,665 )     23,990       64,667  
Accrued compensation and related liabilities     —         —         26,944  
Interest payable     90,528       80,632       41,171  
Other Operating Activities     —         —         —    
Net Cash Used in Operating Activities     (319,687 )     (103,600 )     6,018  
Investing Activities:                        
Pre-acquisition costs and deposits     (1,606,099 )     —         —    
Cash received from derivative forward contract     —         —         —    
Net Cash Used in Investing Activities     (1,606,099 )     —         —    
Financing Activities:                        
Debt issuance costs     (150,000 )     —         —    
Proceeds from exercise of stock options     17,500       —         —    
Net Cash Used in Financing Activities     132,500       —         —    
                         
Net change in Cash and Cash Equivalents     (2,058,286 )     (103,599 )     6,018  
Cash and Cash Equivalents at Beginning of Period     2,275,500       161,014       64,978  
Cash and Cash Equivalents at End of Period   $ 217,214     $ 57,415     $ 70,996  

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the three months ended September 30,
    2016
Operating Activities:        
Net loss   $ (43,729 )
Adjustments to reconcile net loss to net cash used in operating activities:        
Foreign currency transaction gain     —    
Gain on settlement of liabilities     —    
Share-based compensation     —    
Write-down of long lived assets     —    
Loss on disposal of fixed assets     —    
Depreciation and amortization     62,947  
Amortization of debt discount     —    
Change in fair value of derivative     —    
Changes in operating assets and liabilities:        
Accounts receivable     (24,665 )
Inventory     (745 )
Accounts payable and accrued expenses     (94,086 )
Accrued compensation and related liabilities     54,087  
Interest payable     52,301  
Other Operating Activities     —    
Other current assets     (2,627 )
Other noncurrent assets     —    
Net Cash Used in Operating Activities     4,974  
Investing Activities:        
Plantation developments costs     —    
Proceeds from sale of property and equipment     —    
Net Cash Used in Investing Activities     —    
Financing Activities:        
Proceeds from issuance of preferred membership in GCE Mexico I, LLC     —    
Net Cash Provided by Financing Activities     —    
Cash Flows of discontinued operations:        
Operating cash flows        
Investing cash flows     —    
Financing cash flows (including cash at year-end)     —    
Net Cash flows from discontinued operations     —    
         
Effect of exchange rate changes on cash     —    
         
Net Change in Cash and Cash Equivalents     4,974  
Cash and Cash Equivalents at Beginning of Period     12,205  
Cash and Cash Equivalents at End of Period   $ 17,179  

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the nine months ended September 30,
    2019   2018   2017
Operating Activities:                        
Net loss   $ (5,881,564 )   $ (390,247 )   $ (773,904 )
Adjustments to reconcile net loss to net cash used in operating activities:                        
Gain on settlement of liabilities     —         —         —    
Share-based compensation     575,145       69,289       35,560  
Depreciation and amortization     183,919       183,920       183,920  
Change in fair value of derivative liability     2,213,000       —         —    
Changes in operating assets and liabilities:                        
Accounts receivable     —         —         112,254  
Inventory     —         —         —    
Accounts payable and accrued expenses     722,642       (48,626 )     139,226  
Accrued compensation and related liabilities     (21 )     (2,549 )     80,833  
Interest payable     271,585       241,894       270,943  
Other Operating Activities     —         —         —    
Net Cash Used in Operating Activities     (1,915,294 )     53,681       48,832  
Investing Activities:                        
Pre-acquisition costs and deposits     (2,861,481 )                
Net Cash Used in Investing Activities     (2,861,481 )     —         —    
Financing Activities:                        
Debt issuance costs     (250,000 )                
Proceeds from exercise of stock options     17,500       —         —    
Net Cash Used in Financing Activities     (232,500 )     —         —    
                         
Net Change in Cash and Cash Equivalents     (5,009,275 )     53,681       48,832  
Cash and Cash Equivalents at Beginning of Period     5,226,489       3,733       22,164  
Cash and Cash Equivalents at End of Period   $ 217,214     $ 57,414     $ 70,996  

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    For the nine months ended September 30,
    2016
Operating Activities:        
Net loss   $ (211,981 )
Adjustments to reconcile net loss to net cash used in operating activities:        
Foreign currency transaction gain     —    
Gain on settlement of liabilities     (255,752 )
Share-based compensation     31,311  
Write-down of long-lived assets     —    
Loss on disposal of fixed assets     —    
Depreciation and amortization     187,976  
Amortization of debt discount     —    
Change in fair value of derivative     (106,000 )
Changes in operating assets and liabilities:        
Accounts receivable     (77,429 )
Inventory     2,858  
Accounts payable and accrued expenses     (123,864 )
Accrued compensation and related liabilities     158,653  
Interest payable     230,445  
Other current assets     34,219  
Other noncurrent assets     —    
Net Cash Used in Operating Activities     (129,564 )
Investing Activities:        
Plantation developments costs     —    
Proceeds from sale of property and equipment     —    
Net Cash Used in Investing Activities     —    
Financing Activities:        
Proceeds from issuance of preferred membership in GCE Mexico I, LLC        
Net Cash Provided by Financing Activities     —    
Cash Flows of discontinued operations:        
Operating cash flows     218,015  
Investing cash flows     —    
Financing cash flows (including cash at year-end)     —    
Net Cash flows from discontinued operations     218,015  
         
Effect of exchange rate changes on cash     (105,976 )
         
Net Change in Cash and Cash Equivalents     (17,525 )
Cash and Cash Equivalents at Beginning of Period     34,704  
Cash and Cash Equivalents at End of Period   $ 17,179